4531 — Yuki Gosei Kogyo Co Share News
0.000.00%
Last trade - 00:00To Acquire 5.08% Voting Rights In Yuki Gosei Kogyo As Part Of Agreement To Start Collaboration In Nucleic Acid Therapeutics CDMO Business
Table: Yuki Gosei - 9-MTH parent results
Table: Yuki Gosei - 6-MTH parent results
Table: Yuki Gosei - Q1 parent results
Table: Yuki Gosei -2024/25 parent results
Table: Yuki Gosei - 9-MTH parent results
Table: Yuki Gosei - Q1 parent results
Table: Yuki Gosei -2023/24 parent results
Table: Yuki Gosei -2023/24 parent forecast
Table: Yuki Gosei -2023/24 div forecast
Table: Yuki Gosei - 9-MTH parent results
Table: Yuki Gosei - 6-MTH parent results
Table: Yuki Gosei - Q1 parent results
Table: Yuki Gosei -2022/23 parent forecast
Table: Yuki Gosei -2022/23 div forecast
Table: Yuki Gosei -2022/23 parent results
Table: Yuki Gosei - 9-MTH parent results
Table: Yuki Gosei - 6-MTH parent results
Table: Yuki Gosei - Q1 parent results